Initial experience with cardiac contractility modulation devices in Latin America for the treatment of heart failure

CONCLUSIONS: The modulation of cardiac contractility is currently a treatment option for patients with heart failure in functional class III-IV, with LVEF 25-45%, and a QRS < 130 ms who are not candidates for cardiac resynchronization therapy.PMID:38631374 | DOI:10.24875/ACM.24000021

Source: Archivos de Cardiologia de Mexico - April 17, 2024 Category: Cardiology Authors: Ulises Rojel-Mart ínez Carlos De-la-Fuente-Macip Arturo Enr íquez-Silverio Karla I Bozada-Nolasco Pablo A Re átiga-Vega Flor M Marquez Marquez-Maldonado Source Type: research